| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |